Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Impact of Dietary Diversity on Postprandial Insulin Secretion and Metabolism

10 november 2026 uppdaterad av: Prof. Dr. Dr. Anja Bosy-Westphal, University of Kiel

This randomized, controlled, crossover dietary intervention will test whether a three-week diverse diet, compared with a control diet with lower food diversity, changes postprandial insulin responses, other metabolic parameters, and the gut microbiome in 34 healthy adults with overweight. Participants will complete both diets in a randomized order, separated by a four-week washout period. The intervention periods will be conducted under free-living conditions, with study foods provided by the research center. Before and after each intervention period, postprandial metabolism will be assessed using standardized meal tests conducted under controlled whole-room calorimetry conditions. The primary outcome is the log-transformed total postprandial insulin area under the concentration-time curve from 0 to 240 minutes.

Studieöversikt

Status

Har inte rekryterat ännu

Studietyp

Interventionell

Inskrivning (Beräknad)

34

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

    • Schleswig-Holstein
      • Kiel, Schleswig-Holstein, Tyskland, 24105
        • Institute of Human Nutrition and Food Science , Department Human Nutrition
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 60 år (Vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Healthy adults with overweight.
  • Age 18-60 years.
  • Body mass index (BMI) >=25 and <30 kg/m2.
  • Men and women; the study plans an equal distribution of biological sex.
  • No regular sports participation; regular sporting activity >=2 h/week is excluded.
  • German-speaking, because the study questionnaires are in German and not validated in other languages.
  • No anemia or iron deficiency based on screening hemoglobin and ferritin.
  • Women of childbearing potential must use hormonal contraception (e.g., pill, hormonal IUD, contraceptive patch, vaginal ring, 3-month injection, or hormonal implant) and have pregnancy excluded by hCG testing.
  • Able and willing to provide written informed consent.

Exclusion Criteria:

  • - Individuals unable to provide informed written consent.
  • Vegetarian or vegan diet.
  • Habitual consumption of more than 5 caffeinated beverages per day.
  • Chronic diseases.
  • Regular medication use, except oral contraceptives.
  • Antibiotic use within 6 weeks before study start.
  • Anemia and/or iron deficiency.
  • Pregnancy or breastfeeding.
  • Cigarette and/or cannabis use, including vaping.
  • Food allergies and/or food intolerances.
  • Current weight-reduction diet or weight loss >5 kg within the previous 3 months.
  • Regular sporting activity >=2 h/week.
  • Claustrophobia/fear of confined spaces because of EchoMRI assessment.
  • Active participation in another study.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Övrig
  • Tilldelning: Randomiserad
  • Interventionsmodell: Crossover tilldelning
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Control Diet -> Diverse Diet

Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet.

Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet.

Experimentell: Diverse Diet -> Control Diet

Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet.

Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Postprandial Insulin
Tidsram: 0-240 minutes

fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

0-240 minutes

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Postprandial Glucose
Tidsram: 0-240 minutes

fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

0-240 minutes
C-Peptide
Tidsram: 24 hours

Urinary c-peptide excretion during the 24h stay in the whole-room indirect calorimeter.

24 hours
Non-esterified fatty acids
Tidsram: 0-240 minutes

fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

0-240 minutes
Triglycerides
Tidsram: 0-240 minutes

fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

0-240 minutes
Appetite-relatied hormones (GLP-1, PYY, Ghrelin)
Tidsram: 0-240 minutes

fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

0-240 minutes
Subjective Appetite
Tidsram: 0-300 minutes

measured with visual analogue scales (5 hours AUC; mm x 5 hours) after a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side.

0-300 minutes
Energy Expenditure and macronutrient oxidation
Tidsram: 24 hours

measured during the 24h stay with indirect calorimetry in a whole-room indirect calorimeter (kcal/day) at the beginning and end of each three-week intervention period, i.e., twice per intervention.

24 hours
Gut microbiome composition and Microbiome diversity
Tidsram: Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.

taxonomy and function via shotgun metagenome sequencing

Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 februari 2027

Primärt slutförande (Beräknad)

1 september 2029

Avslutad studie (Beräknad)

1 juli 2030

Studieregistreringsdatum

Först inskickad

19 oktober 2026

Först inskickad som uppfyllde QC-kriterierna

10 november 2026

Första postat (Faktisk)

16 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

16 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

10 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera